Ahdistuksen vaikutukset neuropaattisessa kivussa ja pregabaliinin ahdistusta moduloiva vaikutus funktionaalisella magneettikuvauksella (fMRI) tutkittuna

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-004464-31-FI

Enrollment

Registered

2006-08-16

Start date

2006-10-03

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropaattinen kipu ahdistuneisuus MedDRA version: 8.1 Level: LLT Classification code 10002855 Term: Anxiety

Interventions

Trade Name: LYRICA Pharmaceutical Form: INN or Proposed INN: PREGABALIN CAS Number: 148553508

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026